Howard J Seltman1, Shaina Mitchell2, Robert A Sweet3,4,5. 1. Department of Statistics, Carnegie Mellon University, Pittsburgh, PA, USA. 2. Department of Biostatistics, University of North Carolina Chapel Hill, NC, USA. 3. Department of Psychiatry, University of Pittsburgh, PA, USA. 4. Department of Neurology, University of Pittsburgh, PA, USA. 5. VISN 4 Mental Illness Research, Education and Clinical Center (MIRECC), VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
Abstract
OBJECTIVE: Psychosis, like other neuropsychiatric symptoms of dementia, has many features that make predictive modeling of its onset difficult. For example, psychosis onset is associated with both the absolute degree of cognitive impairment and the rate of cognitive decline. Moreover, psychotic symptoms, while more likely than not to persist over time within individuals, may remit and recur. To facilitate predictive modeling of psychosis for personalized clinical decision making, including evaluating the role of risk genes in its onset, we have developed a novel Bayesian model of the dual trajectories of cognition and psychosis symptoms. METHODS: Cognition was modeled as a four-parameter logistic curve with random effects for all four parameters and possible covariates for the rate and time of fall. Psychosis was modeled as a continuous-time hidden Markov model with a latent never-psychotic class and states for pre-psychotic, actively psychotic and remitted psychosis. Covariates can affect the probability of being in the never-psychotic class. Covariates and the level of cognition can affect the transition rates for the hidden Markov model. RESULTS: The model characteristics were confirmed using simulated data. Results from 434 AD patients show that a decline in cognition is associated with an increased rate of transition to the psychotic state. CONCLUSIONS: The model allows declining cognition as an input for psychosis prediction, while incorporating the full uncertainty of the interpolated cognition values. The techniques used can be used in future genetic studies of AD and are generalizable to the study of other neuropsychiatric symptoms in dementia.
OBJECTIVE:Psychosis, like other neuropsychiatric symptoms of dementia, has many features that make predictive modeling of its onset difficult. For example, psychosis onset is associated with both the absolute degree of cognitive impairment and the rate of cognitive decline. Moreover, psychotic symptoms, while more likely than not to persist over time within individuals, may remit and recur. To facilitate predictive modeling of psychosis for personalized clinical decision making, including evaluating the role of risk genes in its onset, we have developed a novel Bayesian model of the dual trajectories of cognition and psychosis symptoms. METHODS: Cognition was modeled as a four-parameter logistic curve with random effects for all four parameters and possible covariates for the rate and time of fall. Psychosis was modeled as a continuous-time hidden Markov model with a latent never-psychotic class and states for pre-psychotic, actively psychotic and remitted psychosis. Covariates can affect the probability of being in the never-psychotic class. Covariates and the level of cognition can affect the transition rates for the hidden Markov model. RESULTS: The model characteristics were confirmed using simulated data. Results from 434 ADpatients show that a decline in cognition is associated with an increased rate of transition to the psychotic state. CONCLUSIONS: The model allows declining cognition as an input for psychosis prediction, while incorporating the full uncertainty of the interpolated cognition values. The techniques used can be used in future genetic studies of AD and are generalizable to the study of other neuropsychiatric symptoms in dementia.
Authors: O L Lopez; J T Becker; W Klunk; J Saxton; R L Hamilton; D I Kaufer; R A Sweet; C Cidis Meltzer; S Wisniewski; M I Kamboh; S T DeKosky Journal: Neurology Date: 2000-12-26 Impact factor: 9.910
Authors: O L Lopez; J T Becker; W Klunk; J Saxton; R L Hamilton; D I Kaufer; R A Sweet; C Cidis Meltzer; S Wisniewski; M I Kamboh; S T DeKosky Journal: Neurology Date: 2000-12-26 Impact factor: 9.910
Authors: Elise A Weamer; James E Emanuel; Daniel Varon; Sachiko Miyahara; Patricia A Wilkosz; Oscar L Lopez; Steven T Dekosky; Robert A Sweet Journal: Int Psychogeriatr Date: 2008-09-25 Impact factor: 3.878
Authors: Oscar L Lopez; William J Jagust; Steven T DeKosky; James T Becker; Annette Fitzpatrick; Corinne Dulberg; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller Journal: Arch Neurol Date: 2003-10
Authors: P N Tariot; J L Mack; M B Patterson; S D Edland; M F Weiner; G Fillenbaum; L Blazina; L Teri; E Rubin; J A Mortimer Journal: Am J Psychiatry Date: 1995-09 Impact factor: 18.112
Authors: Robert A Sweet; Howard Seltman; James E Emanuel; Oscar L Lopez; James T Becker; Joshua C Bis; Elise A Weamer; Mary Ann A DeMichele-Sweet; Lewis H Kuller Journal: Am J Psychiatry Date: 2012-09 Impact factor: 18.112
Authors: Elise A Weamer; Mary Ann A DeMichele-Sweet; Yona K Cloonan; Oscar L Lopez; Robert A Sweet Journal: J Clin Psychiatry Date: 2016-12 Impact factor: 4.384
Authors: Lirong Wang; Jian Ying; Peihao Fan; Elise A Weamer; Mary Ann A DeMichele-Sweet; Oscar L Lopez; Julia K Kofler; Robert A Sweet Journal: Am J Geriatr Psychiatry Date: 2019-03-27 Impact factor: 4.105
Authors: Brian M Kelter; Lauren J Shepler; Pengsheng Ni; Mary D Slavin; Amy Acton; Lewis E Kazis; Colleen M Ryan; Jeffrey C Schneider Journal: Burns Date: 2021-12-02 Impact factor: 2.609
Authors: M A A DeMichele-Sweet; E A Weamer; L Klei; D T Vrana; D J Hollingshead; H J Seltman; R Sims; T Foroud; I Hernandez; S Moreno-Grau; L Tárraga; M Boada; A Ruiz; J Williams; R Mayeux; O L Lopez; E L Sibille; M I Kamboh; B Devlin; R A Sweet Journal: Mol Psychiatry Date: 2017-05-02 Impact factor: 15.992